Dolphin Medical Services Past Earnings Performance
Past criteria checks 0/6
Dolphin Medical Services has been growing earnings at an average annual rate of 46.4%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been declining at an average rate of 11.1% per year.
Key information
46.4%
Earnings growth rate
46.6%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -11.1% |
| Return on equity | -1.0% |
| Net Margin | -12.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dolphin Medical Services makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 8 | -1 | 1 | 0 |
| 30 Jun 24 | 7 | -1 | 0 | 0 |
| 31 Mar 24 | 7 | -1 | 1 | 0 |
| 31 Dec 23 | 7 | -1 | 1 | 0 |
| 30 Sep 23 | 7 | -1 | 1 | 0 |
| 30 Jun 23 | 7 | -1 | 0 | 0 |
| 31 Mar 23 | 6 | -1 | 1 | 0 |
| 31 Dec 22 | 7 | -1 | 1 | 0 |
| 30 Sep 22 | 6 | -1 | 1 | 0 |
| 30 Jun 22 | 6 | -2 | 0 | 0 |
| 31 Mar 22 | 6 | -2 | 1 | 0 |
| 31 Dec 21 | 61 | -4 | 1 | 0 |
| 30 Sep 21 | 61 | -3 | 0 | 0 |
| 30 Jun 21 | 60 | -3 | 0 | 0 |
| 31 Mar 21 | 60 | -3 | 1 | 0 |
| 31 Dec 20 | 5 | -2 | 1 | 0 |
| 30 Sep 20 | 4 | -3 | 1 | 0 |
| 30 Jun 20 | 3 | -3 | 0 | 0 |
| 31 Mar 20 | 2 | -4 | 1 | 0 |
| 31 Dec 19 | 2 | -9 | 0 | 0 |
| 30 Sep 19 | 1 | -10 | 0 | 0 |
| 30 Jun 19 | 1 | -11 | 0 | 0 |
| 31 Mar 19 | 1 | -10 | 0 | 0 |
| 31 Dec 18 | 2 | -3 | 0 | 0 |
| 30 Sep 18 | 2 | -3 | 0 | 0 |
| 30 Jun 18 | 2 | -2 | 0 | 0 |
| 31 Mar 18 | 2 | -3 | 0 | 0 |
| 31 Dec 17 | 3 | -5 | 1 | 0 |
| 31 Mar 17 | 5 | -3 | 1 | 0 |
| 31 Mar 16 | 7 | 0 | 1 | 0 |
| 31 Mar 15 | 4 | -6 | 1 | 0 |
| 31 Mar 14 | 10 | -9 | 3 | 0 |
Quality Earnings: 526504 is currently unprofitable.
Growing Profit Margin: 526504 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 526504 is unprofitable, but has reduced losses over the past 5 years at a rate of 46.4% per year.
Accelerating Growth: Unable to compare 526504's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 526504 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (33.2%).
Return on Equity
High ROE: 526504 has a negative Return on Equity (-0.98%), as it is currently unprofitable.